Problem statement: Hypoxic-ischemic encephalopathy is one of the leading causes of neonatal death and permanent neurological dysfunction worldwide. It has recently been shown that activation of mGluR2/3 before or after ischemic injury leads to neuroprotection, but the exact mechanism of this effect is unclear. Purpose: The purpose of this study is to investigate whether activation of group II glutamate receptor agonists (mGluR2/3) after hypoxia-ischemia can reduce brain damage and inhibit cell apoptosis. Method: We used an animal model of hypoxic-ischemia (HI) in 7-day-old pups. The animals received unilateral carotid artery ligation combined with hypoxia for 75 minutes under 7.4% oxygen
Journal of Cognitive Neuropsychology received 8 citations as per Google Scholar report